Login

Topol on Deep Medicine

Eric Topol, founder and director of Scripps Research Translational Institute and Reading Frames author, discusses the future of the doctor-patient bond in an era of artificial intelligence–driven medicine.

The Scientist Staff

Jul 15, 2019

Read the full story.

Related Articles

colored microscope photo of xenobot

“Xenobot” Living Robots Can Reproduce

“Xenobot” Living Robots Can Reproduce

Infographic showing endogenous adenosine enzymes acting on RNA (ADARs) edit genetic material in the cell by attaching to naturally occurring double-stranded RNAs, including mRNAs, and switching out A bases with I bases (left). Therapeutic RNA editing platforms based on this mechanism fall into one of two categories: either they use engineered enzymes, which generally consist of the editing part of the ADAR enzyme attached to another protein such as Cas13 that boosts specificity, alongside a guide RNA that targets the enzyme to the desired location (middle); or they consist of a guide RNA alone, which recruits an endogenous ADAR to edit the target sequence (right).

Infographic: RNA Editing Approaches

Infographic: RNA Editing Approaches

computerized image of different layers of a cell shown at great detail

New Studies Enable a Clearer View Inside Cells

New Studies Enable a Clearer View Inside Cells

a smiling woman standing between a much taller man and woman

Protein Size Matters

Protein Size Matters